Arnav Mehta· @arnavmehta3 · X·· 2026-04-20Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
zoldonrasib and VS-7375 in G12D remain Phase 1 — strong numbers, small samples, not head-to-head.
Body
Incredibly clean safety profile for Zoldonrasib (KRAS G12D)!
@RevMedicines
@AACR
#AACR26
Heat 9 · 7 likes · 0 replies · 2 reposts
Source: Arnav Mehta · x.com